Dr. Wendy Lin is a hematopathologist and physician-scientist in the Department of Pathology and Cell Biology. She earned her MD from National Cheng Kung University, Taiwan, obtained a Ph.D. in Molecular Microbiology and Immunology in the laboratory of Diane E. Griffin, M.D., Ph.D. of Johns Hopkins University, Baltimore, Maryland, where she studied the pathogenesis and immunity of measles virus infection. Following the receipt of her Ph.D., she completed post-doctoral training in the laboratory of Steven L. Reiner, M.D. in the Department of Microbiology and Immunology here at Columbia University Irving Medical Center, where she studied the influence of metabolism on molecular signaling and cell fate decisions during lymphoid differentiation.She subsequently completed an anatomic pathology residency and hematopathology fellowship at New York-Presbyterian Hospital/Columbia University Irving Medical Center, where she also served as a chief resident in Pathology from 2019-2020.

During her residency, Dr. Lin was selected for the National Cancer Institute (NCI) funded R38 training program and completed her physician-scientist research pathway training in the laboratories of Drs. Teresa Palomero and Adolfo Ferrando, where she focused on the immune tumor microenvironment of peripheral T cell lymphomas (PTCL). For her clinical practice, she provides all aspects of diagnostic services in the division of hematopathology. As a recipient of the 2022 ASCO Young Investigator Award and HICCC Early Career Development Pilot Award, she will continue working at the intersection of hematopathology and translational lymphoma research to better understand the pathogenesis and therapeutic modalities of PTCLs.